UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000009607
Receipt number	R000011266
Scientific Title	The double-blind, randomised controlled phase II study of the adjuvant therapy using alpha-galactosylceramide pulsed antigen presenting cells for patients with head and neck mucosal melanoma followed by standard therapy.
Date of disclosure of the study information	2013/04/01
Last modified on	2020/08/15 14:17:19

---